Effect of melatonin versus vitamin D as antioxidant and Hepatoprotective agents in STZ-induced diabetic rats

被引：11

作者：

Alqasim A.A. ^{[1
]}

Noureldin E.E.M. ^{[2
]}

Hammadi S.H. ^{[3
]}

Esheba G.E. ^{[4
]}

机构：

[1] Umm Alqura University, Department of Physiology, College of Medicine, Makkah

[2] Umm Alqura University, Department of Biochemistry, College of Medicine, Makkah

[3] Umm Alqura university, Department of Internal Medicine, College of Medicine, Makkah

[4] Umm Alqura University, Department of Pathology, College of Medicine, Makkah

来源：

Journal of Diabetes & Metabolic Disorders | / 16卷 / 1期

关键词：

Diabetes; Liver; Melatonin; Oxidative stress; Vitamin D;

D O I：

10.1186/s40200-017-0322-6

中图分类号：

学科分类号：

摘要：

Background: Diabetes mellitus (DM) is a serious chronic disease, with multiple complications including hepatopathy associated with imbalance of the oxidative status. The purpose of this study is to observe possible protective effects of vitamin-D and melatonin on glucose profile, antioxidant-oxidant status, lipid peroxidation, and histopathological protection of the liver in streptozotocin-induced diabetic rats. Methods: Eighty three male albino rats were divided into nine groups as follows: G1 (n = 10) Normal control rats; G2 (n = 8) were normal rats treated with melatonin only; G3 (n = 10) were normal rats treated with vitamin D only; G4 (n = 9) were diabetic rats, which received no medications; G5 (n = 8) were diabetic rat treated with insulin only; G6 (n = 10) were diabetic rats treated with melatonin only; G7 (n = 9) were diabetic rats treated with melatonin and insulin; G8 (n = 9) were diabetic rats treated with vitamin D only; G9 (n = 10) were diabetic rats treated with vitamin D and insulin. Two months post treatment, blood was collected to measure: Fasting blood sugar (FBS), glycosylated hemoglobin (HbA1c), fructosamine (FA), total antioxidant capacity (TAC), malondialdahyde (MDA). livers were isolated for histopathological study. Results: As compared to normal rats, our results demonstrate that glucose, fructosamine and HbA1c levels is increased in diabetic groups and declined to lesser levels in treated groups. TAC level of diabetic rats is not significantly changed. Vitamin D administration significantly increased TAC while it is not changed with melatonin either in treated or non-treated groups. The liver of diabetic rats shows only mild focal microvesicular fatty degeneration. The liver of diabetic rats treated with insulin shows degeneration of cell edema in the stroma. The liver of diabetic rats treated with melatonin with or without insulin, exhibited marked improvement. The liver of diabetic rats treated with vitamin D with or without insulin, shows degeneration of cells and edema in the stroma. Conclusion: Our results demonstrated the beneficial antioxidant effect of vitamin D administration to normal and diabetic rats as compared to melatonin. Nevertheless, melatonin still shows more therapeutic effect on liver cell injury induced by induction of diabetes. © 2017 The Author(s).

引用

共 39 条

[1]

Wild S., Roglic G., Green A., Sicree R., King H., Global prevalence of diabetes: estimates for the year 2000 and projections for 2030, Diabetes Care, 27, 5, pp. 1047-1053, (2004)

[2]

Matheus A.S., Tannus L.R., Cobas R.A., Palma C.C., Negrato C.A., Gomes M.B., Impact of diabetes on cardiovascular disease: an update, Int J Hypertens, 2013, (2013)

[3]

Zhang J.J., Meng X., Li Y., Zhou Y., Xu D.P., Li S., Li H.B., Effects of Melatonin on Liver Injuries and Diseases, Int J Mol Sci, 18, 4, (2017)

[4]

Cusi K., Nonalcoholic fatty liver disease in type 2 diabetes mellitus, Curr Opin Endocrinol Diabetes Obes, 16, 2, pp. 141-149, (2009)

[5]

Chavan M., Eage P., Prevalence of fatty liver disease among type-2 diabetes mellitus patients and its relation to insulin resistance, J Assoc Physicians India, 64, 1, (2016)

[6]

Guven A., Yavuz O., Cam M., Ercan F., Bukan N., Comunoglu C., Gokce F., Effects of melatonin on streptozotocin-induced diabetic liver injury in rats, Acta Histochem, 108, 2, pp. 85-93, (2006)

[7]

Nannipieri M., Gonzales C., Baldi S., Posadas R., Williams K., Haffner S.M., Stern M.P., Ferrannini E., Mexico City diabetes s: Liver enzymes, the metabolic syndrome, and incident diabetes: the Mexico City diabetes study, Diabetes Care, 28, 7, pp. 1757-1762, (2005)

[8]

Mohamed J., Nazratun Nafizah A.H., Zariyantey A.H., Budin S.B., Mechanisms of Diabetes-Induced Liver Damage: The role of oxidative stress and inflammation, Sultan Qaboos Univ Med J, 16, 2, pp. e132-e141, (2016)

[9]

Reiter R.J., Tan D.X., Burkhardt S., Reactive oxygen and nitrogen species and cellular and organismal decline: amelioration with melatonin, Mech Ageing Dev, 123, 8, pp. 1007-1019, (2002)

[10]

Wei Y., Chen P., de Bruyn M., Zhang W., Bremer E., Helfrich W., Carbon monoxide-releasing molecule-2 (CORM-2) attenuates acute hepatic ischemia reperfusion injury in rats, BMC Gastroenterol, 10, (2010)

← 1 2 3 4 →